GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rici Healthcare Holdings 1526.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.97

+2.11%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥3.26bn

FY2016FY2025

Net income

CN¥358.3m

FY2016FY2025

Free cash flow

CN¥655.0m

FY2016FY2025

Shareholders' equity

CN¥1.92bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥3.26bnCN¥2.92bnCN¥2.99bnCN¥2.77bnCN¥2.77bnCN¥2.25bnCN¥2.01bnCN¥1.60bnCN¥1.26bnCN¥1.09bn
Gross profitCN¥1.41bnCN¥1.17bnCN¥1.25bnCN¥1.08bnCN¥1.14bnCN¥677.3mCN¥564.6mCN¥450.5mCN¥467.9mCN¥413.1m
Operating incomeCN¥775.8mCN¥607.5mCN¥656.9mCN¥503.9mCN¥602.4mCN¥88.4m−CN¥48.9m−CN¥188.1m−CN¥66.4mCN¥106.1m
Net incomeCN¥358.3mCN¥297.3mCN¥363.8mCN¥339.2mCN¥211.8m−CN¥9.2m−CN¥80.7m−CN¥62.8m−CN¥72.5mCN¥68.7m
Diluted earnings per share0.230.190.230.210.13-0.01-0.05-0.04-0.040.05

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥5.69bnCN¥4.86bnCN¥4.64bnCN¥5.33bnCN¥5.29bnCN¥4.91bnCN¥4.75bnCN¥2.76bnCN¥2.41bnCN¥1.84bn
Cash and short-term investmentsCN¥1.38bnCN¥1.12bnCN¥811.2mCN¥840.0mCN¥915.0mCN¥655.4mCN¥384.4mCN¥577.9mCN¥707.8mCN¥1.03bn
Total liabilitiesCN¥3.69bnCN¥3.48bnCN¥3.52bnCN¥4.27bnCN¥4.61bnCN¥4.52bnCN¥4.09bnCN¥1.93bnCN¥1.32bnCN¥733.8m
DebtCN¥2.35bnCN¥2.30bnCN¥2.27bnCN¥2.30bnCN¥2.74bnCN¥2.90bnCN¥2.66bnCN¥755.4mCN¥605.2mCN¥319.1m
Shareholders' equityCN¥1.92bnCN¥1.35bnCN¥1.13bnCN¥1.11bnCN¥790.3mCN¥590.0mCN¥751.5mCN¥810.1mCN¥1.05bnCN¥1.11bn
Shares outstanding1,590m1,590m1,590m1,590m1,590m1,590m1,590m1,591m1,656m1,449m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥839.2mCN¥790.6mCN¥826.3mCN¥824.0mCN¥794.5mCN¥518.7mCN¥192.5mCN¥49.7mCN¥31.8mCN¥202.1m
Capital spending−CN¥184.1m−CN¥206.2m−CN¥339.2m−CN¥361.7m−CN¥378.7m−CN¥428.0m−CN¥366.3m−CN¥348.4m−CN¥462.9m−CN¥142.7m
Free cash flowCN¥655.0mCN¥584.3mCN¥487.1mCN¥462.3mCN¥415.8mCN¥90.7m−CN¥173.8m−CN¥298.6m−CN¥431.1mCN¥59.4m
Dividends paid—−CN¥75.4m−CN¥177.0m——————−CN¥144.6m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥1.33bnCN¥1.93bnCN¥667.7mCN¥1.69bnCN¥1.23bnCN¥1.71bnCN¥1.50bnCN¥1.83bn
Gross profitCN¥463.7mCN¥932.9mCN¥237.7mCN¥771.5mCN¥396.3mCN¥765.5mCN¥564.6mCN¥892.7m
Operating incomeCN¥117.9mCN¥578.7mCN¥98.5mCN¥421.8mCN¥185.7mCN¥428.4mCN¥265.6mCN¥558.6m
Net incomeCN¥53.2mCN¥293.0mCN¥32.6mCN¥212.3mCN¥85.0mCN¥240.4mCN¥143.9mCN¥366.9m
Diluted earnings per share0.030.180.020.130.050.150.090.23
Cash from operations—CN¥601.0mCN¥256.0mCN¥358.0mCN¥73.0mCN¥708.0mCN¥255.0mCN¥127.0m
Capital spending—−CN¥121.0m−CN¥66.0m−CN¥46.0m−CN¥112.0m−CN¥153.0m−CN¥242.0m−CN¥121.0m
Free cash flow—CN¥480.0mCN¥190.0mCN¥312.0m−CN¥39.0mCN¥555.0mCN¥13.0mCN¥6.0m
Total assetsCN¥5.48bnCN¥5.69bnCN¥5.50bnCN¥4.86bnCN¥4.54bnCN¥4.64bnCN¥4.97bnCN¥5.33bn
Cash and short-term investmentsCN¥1.29bnCN¥1.38bnCN¥1.20bnCN¥1.12bnCN¥587.1mCN¥811.2mCN¥665.4mCN¥840.0m
DebtCN¥713.1mCN¥2.35bnCN¥2.62bnCN¥2.30bnCN¥2.31bnCN¥2.27bnCN¥2.54bnCN¥2.68bn
Shareholders' equityCN¥1.96bnCN¥1.92bnCN¥1.63bnCN¥1.35bnCN¥1.21bnCN¥1.13bnCN¥1.25bnCN¥1.11bn

Financial ratios

Data as of 3 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2015FY2014
Gross margin43.2%39.9%41.8%39.0%41.0%30.2%——
Operating margin24.3%21.4%22.5%18.2%21.9%4.0%——
Net margin11.0%10.2%12.2%12.2%7.6%-0.4%——
Return on equity18.7%22.1%32.3%30.5%26.8%-1.6%——
Return on assets6.3%6.1%7.8%6.4%4.0%-0.2%——
Free cash flow yield58.1%66.0%77.1%67.3%66.6%53.7%——
Revenue growth-4.4%-2.3%26.0%-0.1%23.5%11.5%——
Earnings growth3.3%-18.3%25.1%60.2%-2405.1%-88.6%——
Current ratio0.98x0.84x0.66x0.63x0.71x0.62x——
Debt to equity0.55x0.79x1.00x1.26x2.27x2.73x——
Equity ratio33.7%27.7%24.3%20.9%14.9%12.0%——
Interest coverage6.78x4.89x5.29x3.51x4.21x0.46x——
R&D as a share of sales——————0.6%0.5%
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.0%0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.6%7.7%13.3%
Operating income15.5%54.4%24.6%
Net income1.8%—26.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin41.6%41.1%39.6%37.5%
Operating margin22.4%21.3%19.1%13.1%
Net margin10.6%11.4%9.2%6.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings4.56.34.72.29.3-141.9-17.4-44.3-47.741.3
Price to sales0.50.60.60.30.70.60.71.72.82.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 10 Sept 2024.

FY2024FY2023
Paid in the year0.0450.13

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.